Cancer-associated fibroblast-derived protein S100-A11 influences the response to anti-HER2 therapies in HER2-positive breast cancer
Author:
Melani Luque,Miriam Morales-Gallego,Marta Sanz-Álvarez,Claudia Arguiñano,Yamileth Rangel,Natalia Ramírez-Merino,Mengjuan Qin,Ana Rovira,Joan Albanell,Juan Madoz-Gúrpide,Federico Rojo
© 2026 The Authors. Published by Elsevier Inc.